ArticleApplied microbiology and biotechnology2026
Reduced efficacy of food-chain biocides and preservatives against ciprofloxacin-resistant Salmonella Typhimurium.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A wide range of microbial prevention and control strategies are applied along the agri-food chain to combat the transmission of foodborne pathogens to the final consumer. These strategies range from traditional thermal treatments to emerging technologies as well as the use of food chain biocides to reduce microbial loads on raw materials and food contact surfaces, and preservatives for the preservation of feed and food products. However, bacteria have demonstrated a remarkable ability to adapt to and overcome these food-related stresses, often resulting in reduced susceptibility to other seemingly unrelated agents through cross-protection mechanisms. In this study, we aimed to evaluate the outcomes of ciprofloxacin (CIP) antimicrobial resistance (AMR) in Salmonella Typhimurium and its potential relationship with cross-protection to food-chain biocides and preservatives, as well as the ability of the resistant variants (RVs) to retain their virulence. The CIP-RVs showed heterogeneous and compound-dependent responses to the tested food-chain antimicrobial compounds. All five RVs displayed increased tolerance to at least one compound, but cross-protection was not uniform across strains or treatments. Notably, SeT
Indexed as
Identifiers
42909625What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.